CLASS ACTION UPDATE for OPK, ALNY and CHGG: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

Globe Newswire 8-Nov-2018 1:00 PM

NEW YORK, Nov. 08, 2018 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court and further details about the cases can be found at the links provided. There is no cost or obligation to you.

OPKO Health Inc. (NASDAQ:OPK)
Class Period: September 26, 2013 - September 7, 2018
Lead Plaintiff Deadline: November 13, 2018
Join the action: https://www.zlk.com/pslra-1/opko-health-inc-loss-form?wire=3

About the lawsuit: During the class period, OPKO Health Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (1) OPKO and its Chairman and Chief Executive Officer, Phillip Frost, were engaged in a pump-and-dump scheme with several other individuals and companies in their investments in several penny stocks; (2) this illicit scheme would result in governmental scrutiny including from the SEC; and (3) as a result, defendants' statements about OPKO's business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

To learn more about the OPKO Health Inc. class action contact jlevi@levikorsinsky.com.

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)
Class Period: February 15, 2018 - September 12, 2018
Lead Plaintiff Deadline: November 26, 2018
Join the action: https://www.zlk.com/pslra-1/alnylam-pharmaceuticals-inc-loss-form?wire=3

About the lawsuit: Alnylam Pharmaceuticals, Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (1) Alnylam overstated the efficacy and safety of its Onpattro (patisiran) lipid complex injection; and (2) as a result, Alnylam's public statements were materially false and misleading at all relevant times.

To learn more about the Alnylam Pharmaceuticals, Inc. class action contact jlevi@levikorsinsky.com.

Chegg, Inc. (NYSE:CHGG)
Class Period: July 30, 2018 - September 25, 2018
Lead Plaintiff Deadline: November 26, 2018
Join the action: https://www.zlk.com/pslra-1/chegg-inc-loss-form?wire=3

About the lawsuit: Chegg, Inc. allegedly made materially false and/or misleading statements during the class period and/or failed to disclose that: (1) the Company lacked adequate security measures to protect users' data; (2)  the Company lacked the internal controls and procedures to detect unauthorized access to its systems and to its data; (3)  as a result, the Company would incur additional expenses and litigation risks; and (4) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially false and/or misleading and/or lacked a reasonable basis.

To learn more about the Chegg, Inc. class action contact jlevi@levikorsinsky.com.

You have until the lead plaintiff deadlines to request the court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com

Image for Press Release 721059

250x148_zlk.jpg

Image for Press Release 721059

Wait, Before You Leave...